Request for Covid-19 Impact Assessment of this Report
Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Therapeutic Drug Monitoring in these regions, from 2012 to 2022 (forecast).
United States Therapeutic Drug Monitoring market competition by top manufacturers/players, with Therapeutic Drug Monitoring sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
F. Hoffmann-La Roche AG
Siemens Healthcare
Thermo Fisher Scientific
Bio-Rad Laboratories Inc.
Danaher Corporation
...
On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
Blood Test
Urine Test
Saliva Test
Other Test
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Therapeutic Drug Monitoring for each application, including
Hospital Laboratories
Commercial/Private Laboratories
Others
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Therapeutic Drug Monitoring Market Report 2017
1 Therapeutic Drug Monitoring Overview
1.1 Product Overview and Scope of Therapeutic Drug Monitoring
1.2 Classification of Therapeutic Drug Monitoring by Product Category
1.2.1 United States Therapeutic Drug Monitoring Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Therapeutic Drug Monitoring Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Blood Test
1.2.4 Urine Test
1.2.5 Saliva Test
1.2.6 Other Test
1.3 United States Therapeutic Drug Monitoring Market by Application/End Users
1.3.1 United States Therapeutic Drug Monitoring Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Hospital Laboratories
1.3.3 Commercial/Private Laboratories
1.3.4 Others
1.4 United States Therapeutic Drug Monitoring Market by Region
1.4.1 United States Therapeutic Drug Monitoring Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Therapeutic Drug Monitoring Status and Prospect (2012-2022)
1.4.3 Southwest Therapeutic Drug Monitoring Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Therapeutic Drug Monitoring Status and Prospect (2012-2022)
1.4.5 New England Therapeutic Drug Monitoring Status and Prospect (2012-2022)
1.4.6 The South Therapeutic Drug Monitoring Status and Prospect (2012-2022)
1.4.7 The Midwest Therapeutic Drug Monitoring Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Therapeutic Drug Monitoring (2012-2022)
1.5.1 United States Therapeutic Drug Monitoring Sales and Growth Rate (2012-2022)
1.5.2 United States Therapeutic Drug Monitoring Revenue and Growth Rate (2012-2022)
2 United States Therapeutic Drug Monitoring Market Competition by Players/Suppliers
2.1 United States Therapeutic Drug Monitoring Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Therapeutic Drug Monitoring Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Therapeutic Drug Monitoring Average Price by Players/Suppliers (2012-2017)
2.4 United States Therapeutic Drug Monitoring Market Competitive Situation and Trends
2.4.1 United States Therapeutic Drug Monitoring Market Concentration Rate
2.4.2 United States Therapeutic Drug Monitoring Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Therapeutic Drug Monitoring Manufacturing Base Distribution, Sales Area, Product Type
3 United States Therapeutic Drug Monitoring Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Therapeutic Drug Monitoring Sales and Market Share by Region (2012-2017)
3.2 United States Therapeutic Drug Monitoring Revenue and Market Share by Region (2012-2017)
3.3 United States Therapeutic Drug Monitoring Price by Region (2012-2017)
4 United States Therapeutic Drug Monitoring Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Therapeutic Drug Monitoring Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Therapeutic Drug Monitoring Revenue and Market Share by Type (2012-2017)
4.3 United States Therapeutic Drug Monitoring Price by Type (2012-2017)
4.4 United States Therapeutic Drug Monitoring Sales Growth Rate by Type (2012-2017)
5 United States Therapeutic Drug Monitoring Sales (Volume) by Application (2012-2017)
5.1 United States Therapeutic Drug Monitoring Sales and Market Share by Application (2012-2017)
5.2 United States Therapeutic Drug Monitoring Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
6 United States Therapeutic Drug Monitoring Players/Suppliers Profiles and Sales Data
6.1 F. Hoffmann-La Roche AG
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Therapeutic Drug Monitoring Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 F. Hoffmann-La Roche AG Therapeutic Drug Monitoring Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Siemens Healthcare
6.2.2 Therapeutic Drug Monitoring Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Siemens Healthcare Therapeutic Drug Monitoring Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Thermo Fisher Scientific
6.3.2 Therapeutic Drug Monitoring Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Thermo Fisher Scientific Therapeutic Drug Monitoring Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Bio-Rad Laboratories Inc.
6.4.2 Therapeutic Drug Monitoring Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Bio-Rad Laboratories Inc. Therapeutic Drug Monitoring Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Danaher Corporation
6.5.2 Therapeutic Drug Monitoring Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Danaher Corporation Therapeutic Drug Monitoring Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
...
7 Therapeutic Drug Monitoring Manufacturing Cost Analysis
7.1 Therapeutic Drug Monitoring Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Therapeutic Drug Monitoring
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Therapeutic Drug Monitoring Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Therapeutic Drug Monitoring Major Manufacturers in 2016
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 United States Therapeutic Drug Monitoring Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Therapeutic Drug Monitoring Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Therapeutic Drug Monitoring Sales Volume Forecast by Type (2017-2022)
11.3 United States Therapeutic Drug Monitoring Sales Volume Forecast by Application (2017-2022)
11.4 United States Therapeutic Drug Monitoring Sales Volume Forecast by Region (2017-2022)
12 Research Findings and Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
Figure Product Picture of Therapeutic Drug Monitoring
Figure United States Therapeutic Drug Monitoring Market Size (K Units) by Type (2012-2022)
Figure United States Therapeutic Drug Monitoring Sales Volume Market Share by Type (Product Category) in 2016
Figure Blood Test Product Picture
Figure Urine Test Product Picture
Figure Saliva Test Product Picture
Figure Other Test Product Picture
Figure United States Therapeutic Drug Monitoring Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Therapeutic Drug Monitoring by Application in 2016
Figure Hospital Laboratories Examples
Table Key Downstream Customer in Hospital Laboratories
Figure Commercial/Private Laboratories Examples
Table Key Downstream Customer in Commercial/Private Laboratories
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Therapeutic Drug Monitoring Market Size (Million USD) by Region (2012-2022)
Figure The West Therapeutic Drug Monitoring Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Therapeutic Drug Monitoring Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Therapeutic Drug Monitoring Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Therapeutic Drug Monitoring Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Therapeutic Drug Monitoring Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Therapeutic Drug Monitoring Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Therapeutic Drug Monitoring Sales (K Units) and Growth Rate (2012-2022)
Figure United States Therapeutic Drug Monitoring Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Therapeutic Drug Monitoring Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Therapeutic Drug Monitoring Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Therapeutic Drug Monitoring Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Therapeutic Drug Monitoring Sales Share by Players/Suppliers
Figure 2017 United States Therapeutic Drug Monitoring Sales Share by Players/Suppliers
Figure United States Therapeutic Drug Monitoring Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Therapeutic Drug Monitoring Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Therapeutic Drug Monitoring Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Therapeutic Drug Monitoring Revenue Share by Players/Suppliers
Figure 2017 United States Therapeutic Drug Monitoring Revenue Share by Players/Suppliers
Table United States Market Therapeutic Drug Monitoring Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Therapeutic Drug Monitoring Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Therapeutic Drug Monitoring Market Share of Top 3 Players/Suppliers
Figure United States Therapeutic Drug Monitoring Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Therapeutic Drug Monitoring Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Therapeutic Drug Monitoring Product Category
Table United States Therapeutic Drug Monitoring Sales (K Units) by Region (2012-2017)
Table United States Therapeutic Drug Monitoring Sales Share by Region (2012-2017)
Figure United States Therapeutic Drug Monitoring Sales Share by Region (2012-2017)
Figure United States Therapeutic Drug Monitoring Sales Market Share by Region in 2016
Table United States Therapeutic Drug Monitoring Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Therapeutic Drug Monitoring Revenue Share by Region (2012-2017)
Figure United States Therapeutic Drug Monitoring Revenue Market Share by Region (2012-2017)
Figure United States Therapeutic Drug Monitoring Revenue Market Share by Region in 2016
Table United States Therapeutic Drug Monitoring Price (USD/Unit) by Region (2012-2017)
Table United States Therapeutic Drug Monitoring Sales (K Units) by Type (2012-2017)
Table United States Therapeutic Drug Monitoring Sales Share by Type (2012-2017)
Figure United States Therapeutic Drug Monitoring Sales Share by Type (2012-2017)
Figure United States Therapeutic Drug Monitoring Sales Market Share by Type in 2016
Table United States Therapeutic Drug Monitoring Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Therapeutic Drug Monitoring Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Therapeutic Drug Monitoring by Type (2012-2017)
Figure Revenue Market Share of Therapeutic Drug Monitoring by Type in 2016
Table United States Therapeutic Drug Monitoring Price (USD/Unit) by Types (2012-2017)
Figure United States Therapeutic Drug Monitoring Sales Growth Rate by Type (2012-2017)
Table United States Therapeutic Drug Monitoring Sales (K Units) by Application (2012-2017)
Table United States Therapeutic Drug Monitoring Sales Market Share by Application (2012-2017)
Figure United States Therapeutic Drug Monitoring Sales Market Share by Application (2012-2017)
Figure United States Therapeutic Drug Monitoring Sales Market Share by Application in 2016
Table United States Therapeutic Drug Monitoring Sales Growth Rate by Application (2012-2017)
Figure United States Therapeutic Drug Monitoring Sales Growth Rate by Application (2012-2017)
Table F. Hoffmann-La Roche AG Basic Information List
Table F. Hoffmann-La Roche AG Therapeutic Drug Monitoring Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche AG Therapeutic Drug Monitoring Sales Growth Rate (2012-2017)
Figure F. Hoffmann-La Roche AG Therapeutic Drug Monitoring Sales Market Share in United States (2012-2017)
Figure F. Hoffmann-La Roche AG Therapeutic Drug Monitoring Revenue Market Share in United States (2012-2017)
Table Siemens Healthcare Basic Information List
Table Siemens Healthcare Therapeutic Drug Monitoring Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Siemens Healthcare Therapeutic Drug Monitoring Sales Growth Rate (2012-2017)
Figure Siemens Healthcare Therapeutic Drug Monitoring Sales Market Share in United States (2012-2017)
Figure Siemens Healthcare Therapeutic Drug Monitoring Revenue Market Share in United States (2012-2017)
Table Thermo Fisher Scientific Basic Information List
Table Thermo Fisher Scientific Therapeutic Drug Monitoring Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Thermo Fisher Scientific Therapeutic Drug Monitoring Sales Growth Rate (2012-2017)
Figure Thermo Fisher Scientific Therapeutic Drug Monitoring Sales Market Share in United States (2012-2017)
Figure Thermo Fisher Scientific Therapeutic Drug Monitoring Revenue Market Share in United States (2012-2017)
Table Bio-Rad Laboratories Inc. Basic Information List
Table Bio-Rad Laboratories Inc. Therapeutic Drug Monitoring Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bio-Rad Laboratories Inc. Therapeutic Drug Monitoring Sales Growth Rate (2012-2017)
Figure Bio-Rad Laboratories Inc. Therapeutic Drug Monitoring Sales Market Share in United States (2012-2017)
Figure Bio-Rad Laboratories Inc. Therapeutic Drug Monitoring Revenue Market Share in United States (2012-2017)
Table Danaher Corporation Basic Information List
Table Danaher Corporation Therapeutic Drug Monitoring Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Danaher Corporation Therapeutic Drug Monitoring Sales Growth Rate (2012-2017)
Figure Danaher Corporation Therapeutic Drug Monitoring Sales Market Share in United States (2012-2017)
Figure Danaher Corporation Therapeutic Drug Monitoring Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Therapeutic Drug Monitoring
Figure Manufacturing Process Analysis of Therapeutic Drug Monitoring
Figure Therapeutic Drug Monitoring Industrial Chain Analysis
Table Raw Materials Sources of Therapeutic Drug Monitoring Major Players/Suppliers in 2016
Table Major Buyers of Therapeutic Drug Monitoring
Table Distributors/Traders List
Figure United States Therapeutic Drug Monitoring Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Therapeutic Drug Monitoring Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Therapeutic Drug Monitoring Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Therapeutic Drug Monitoring Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Therapeutic Drug Monitoring Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Therapeutic Drug Monitoring Sales Volume (K Units) Forecast by Type in 2022
Table United States Therapeutic Drug Monitoring Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Therapeutic Drug Monitoring Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Therapeutic Drug Monitoring Sales Volume (K Units) Forecast by Application in 2022
Table United States Therapeutic Drug Monitoring Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Therapeutic Drug Monitoring Sales Volume Share Forecast by Region (2017-2022)
Figure United States Therapeutic Drug Monitoring Sales Volume Share Forecast by Region (2017-2022)
Figure United States Therapeutic Drug Monitoring Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...